Studying the clinical value of GDNF and other biological markers in patients with chronic liver diseases | ||
| Scientific Journal for Damietta Faculty of Science | ||
| Volume 15, Issue 2, August 2025, Pages 140-150 PDF (865.6 K) | ||
| Document Type: Original articles | ||
| DOI: 10.21608/sjdfs.2025.391938.1236 | ||
| Authors | ||
| Ihssin Abdulla Abubaker Faraj* 1; Mohamed Mohamed Abdelaziz2; Lamiaa Deef3; lotfy zakaria habbak4; Amina M. R. El-Sayed5 | ||
| 1Zoology, Faculty of science, Damietta university, Damietta, Egypt. | ||
| 2Gastrointestinal Surgery Center, Faculty of Medicine, Mansoura University | ||
| 3Professor of Molecular Biology, Department of Zoology, Faculty of Science, Damietta University | ||
| 4Zoology department, faculty of science, Damietta University, Damietta, Egypt | ||
| 5Gastrointestinal Surgery Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt. | ||
| Abstract | ||
| Background: Chronic liver disease (CLD) is a degenerative process characterized by hepatic dysfunction and systemic alterations. Glial cell line-derived neurotrophic factor (GDNF), a member of the TGF-β protein family group, has been implicated in cellular survival and tissue response to injury. The current study aimed to assess the serum levels of GDNF in patients with CLD and versus healthy individuals, along with assessing related biochemical and hematological parameters. Methods: The study included 82 participants: 63 patients with CLD and 19 healthy controls. Serum GDNF levels were measured, along with liver and kidney function tests and complete blood counts. Statistical analyses were conducted to compare results across the two categories. Results: Levels of GDNF were markedly higher in the CLD group (median: 2.51 ng/ml) compared to the control group (median: 1.75 ng/ml, P = 0.001). CLD patients showed significant variations in liver function tests, consisting of elevated bilirubin, AST, GGT, and INR, and decreased albumin. Hematological findings revealed lower hemoglobin, hematocrit, and RBC counts, alongside increased RDW and neutrophil-to-lymphocyte ratio. Platelet indices showed reduced counts and altered morphology. Conclusion: The increased GDNF levels in CLD patients suggest a potential role as a non-invasive biomarker. Significant biochemical and hematological alterations further highlight the systemic impact of CLD. These findings support the need for further research into the diagnostic and prognostic utility of GDNF in liver disease. | ||
| Keywords | ||
| Chronic Liver disease (CLD); Platelets indices; Neutrophile to lymphocyte ratio (NLR); Glial cell line-derived neurotrophic factor (GDNF) | ||
|
Statistics Article View: 45 PDF Download: 20 |
||
